OPTIMIZERX CORP (OPRX) Stock Fundamental Analysis
USA - NASDAQ:OPRX - US68401U2042 - Common Stock
19.55 USD
-0.23 (-1.16%)
19.55 USD
0 (0%)
Taking everything into account, OPRX scores 5 out of 10 in our fundamental rating. OPRX was compared to 35 industry peers in the Health Care Technology industry. While OPRX seems to be doing ok healthwise, there are quite some concerns on its profitability. OPRX is not priced too expensively while it is growing strongly. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
OPRX had positive earnings in the past year.
OPRX had a positive operating cash flow in the past year.
OPRX had negative earnings in 4 of the past 5 years.
In multiple years OPRX reported negative operating cash flow during the last 5 years.
1.2 Ratios
OPRX's Return On Assets of -5.83% is fine compared to the rest of the industry. OPRX outperforms 71.43% of its industry peers.
OPRX has a Return On Equity of -8.27%. This is in the better half of the industry: OPRX outperforms 68.57% of its industry peers.
OPRX has a better Return On Invested Capital (1.94%) than 74.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.83% | ||
| ROE | -8.27% | ||
| ROIC | 1.94% |
ROA(3y)-9.94%
ROA(5y)-6.64%
ROE(3y)-13.38%
ROE(5y)-8.85%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
OPRX has a better Operating Margin (3.47%) than 68.57% of its industry peers.
With a Gross Margin value of 64.39%, OPRX perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
In the last couple of years the Gross Margin of OPRX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.47% | ||
| PM (TTM) | N/A | ||
| GM | 64.39% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.49%
GM growth 5Y0.53%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so OPRX is destroying value.
Compared to 1 year ago, OPRX has more shares outstanding
OPRX has more shares outstanding than it did 5 years ago.
OPRX has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 4.58 indicates that OPRX is not in any danger for bankruptcy at the moment.
OPRX's Altman-Z score of 4.58 is fine compared to the rest of the industry. OPRX outperforms 77.14% of its industry peers.
OPRX has a debt to FCF ratio of 2.82. This is a good value and a sign of high solvency as OPRX would need 2.82 years to pay back of all of its debts.
OPRX's Debt to FCF ratio of 2.82 is fine compared to the rest of the industry. OPRX outperforms 68.57% of its industry peers.
A Debt/Equity ratio of 0.21 indicates that OPRX is not too dependend on debt financing.
OPRX has a Debt to Equity ratio (0.21) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.82 | ||
| Altman-Z | 4.58 |
ROIC/WACC0.18
WACC10.64%
2.3 Liquidity
OPRX has a Current Ratio of 2.57. This indicates that OPRX is financially healthy and has no problem in meeting its short term obligations.
OPRX has a Current ratio (2.57) which is comparable to the rest of the industry.
OPRX has a Quick Ratio of 2.57. This indicates that OPRX is financially healthy and has no problem in meeting its short term obligations.
OPRX has a Quick ratio of 2.57. This is comparable to the rest of the industry: OPRX outperforms 51.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.57 | ||
| Quick Ratio | 2.57 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 184.62% over the past year.
OPRX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 101.23% yearly.
OPRX shows a strong growth in Revenue. In the last year, the Revenue has grown by 25.90%.
Measured over the past years, OPRX shows a very strong growth in Revenue. The Revenue has been growing by 30.22% on average per year.
EPS 1Y (TTM)184.62%
EPS 3Y-9.14%
EPS 5Y101.23%
EPS Q2Q%1100%
Revenue 1Y (TTM)25.9%
Revenue growth 3Y14.55%
Revenue growth 5Y30.22%
Sales Q2Q%55.19%
3.2 Future
The Earnings Per Share is expected to grow by 53.84% on average over the next years. This is a very strong growth
OPRX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.46% yearly.
EPS Next Y105.03%
EPS Next 2Y53.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year18.13%
Revenue Next 2Y14.46%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 26.42 indicates a quite expensive valuation of OPRX.
Compared to the rest of the industry, the Price/Earnings ratio of OPRX indicates a rather cheap valuation: OPRX is cheaper than 82.86% of the companies listed in the same industry.
OPRX is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.42, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 25.03, which means the current valuation is very expensive for OPRX.
Based on the Price/Forward Earnings ratio, OPRX is valued a bit cheaper than the industry average as 74.29% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of OPRX to the average of the S&P500 Index (22.94), we can say OPRX is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.42 | ||
| Fwd PE | 25.03 |
4.2 Price Multiples
OPRX's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, OPRX is valued a bit cheaper than 68.57% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 36.04 | ||
| EV/EBITDA | 46.9 |
4.3 Compensation for Growth
OPRX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as OPRX's earnings are expected to grow with 53.84% in the coming years.
PEG (NY)0.25
PEG (5Y)0.26
EPS Next 2Y53.84%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for OPRX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
19.55
-0.23 (-1.16%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners71.3%
Inst Owner Change-0.27%
Ins Owners12.48%
Ins Owner Change2.69%
Market Cap363.04M
Analysts83.08
Price Target19.38 (-0.87%)
Short Float %11.1%
Short Ratio4.69
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)719.07%
Min EPS beat(2)165.36%
Max EPS beat(2)1272.78%
EPS beat(4)4
Avg EPS beat(4)384.3%
Min EPS beat(4)8.43%
Max EPS beat(4)1272.78%
EPS beat(8)7
Avg EPS beat(8)239.4%
EPS beat(12)10
Avg EPS beat(12)170.64%
EPS beat(16)12
Avg EPS beat(16)123.77%
Revenue beat(2)2
Avg Revenue beat(2)21.8%
Min Revenue beat(2)15.05%
Max Revenue beat(2)28.56%
Revenue beat(4)3
Avg Revenue beat(4)7.89%
Min Revenue beat(4)-16.43%
Max Revenue beat(4)28.56%
Revenue beat(8)6
Avg Revenue beat(8)4.64%
Revenue beat(12)7
Avg Revenue beat(12)1.57%
Revenue beat(16)8
Avg Revenue beat(16)0.17%
PT rev (1m)0%
PT rev (3m)17.53%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-48.33%
EPS NY rev (1m)4.74%
EPS NY rev (3m)20.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.42%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.42 | ||
| Fwd PE | 25.03 | ||
| P/S | 3.47 | ||
| P/FCF | 36.04 | ||
| P/OCF | 34.86 | ||
| P/B | 3.04 | ||
| P/tB | 73.74 | ||
| EV/EBITDA | 46.9 |
EPS(TTM)0.74
EY3.79%
EPS(NY)0.78
Fwd EY4%
FCF(TTM)0.54
FCFY2.77%
OCF(TTM)0.56
OCFY2.87%
SpS5.64
BVpS6.42
TBVpS0.27
PEG (NY)0.25
PEG (5Y)0.26
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.83% | ||
| ROE | -8.27% | ||
| ROCE | 2.45% | ||
| ROIC | 1.94% | ||
| ROICexc | 2.18% | ||
| ROICexgc | 16.64% | ||
| OM | 3.47% | ||
| PM (TTM) | N/A | ||
| GM | 64.39% | ||
| FCFM | 9.62% |
ROA(3y)-9.94%
ROA(5y)-6.64%
ROE(3y)-13.38%
ROE(5y)-8.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.49%
GM growth 5Y0.53%
F-Score6
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.82 | ||
| Debt/EBITDA | 3.14 | ||
| Cap/Depr | 7.8% | ||
| Cap/Sales | 0.32% | ||
| Interest Coverage | 0.63 | ||
| Cash Conversion | 130.29% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.57 | ||
| Quick Ratio | 2.57 | ||
| Altman-Z | 4.58 |
F-Score6
WACC10.64%
ROIC/WACC0.18
Cap/Depr(3y)19.52%
Cap/Depr(5y)17.6%
Cap/Sales(3y)0.7%
Cap/Sales(5y)0.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)184.62%
EPS 3Y-9.14%
EPS 5Y101.23%
EPS Q2Q%1100%
EPS Next Y105.03%
EPS Next 2Y53.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)25.9%
Revenue growth 3Y14.55%
Revenue growth 5Y30.22%
Sales Q2Q%55.19%
Revenue Next Year18.13%
Revenue Next 2Y14.46%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y125.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year204.28%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y341.84%
FCF growth 3Y154.28%
FCF growth 5YN/A
OCF growth 1Y173.33%
OCF growth 3Y88.49%
OCF growth 5YN/A